Goldman Sachs Downgrades Abbott Labs (ABT) to Sell Noting Stock has Overreacted to COVID Testing Opportunity
Tweet Send to a Friend
Goldman Sachs analyst Amit Hazan downgraded Abbott Labs (NYSE: ABT) from Neutral to Sell with a price target of $84.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
